← Latest papers
📄 medicine

Testing the feasibility of neurofeedback interventions in mental, behavioural and neurodevelopmental disorders

This paper demonstrates that neurofeedback interventions are feasible to deliver across seven clinical studies targeting various mental, behavioural, and neurodevelopmental disorders, as all studies met pre-defined success criteria for recruitment, retention, and intervention uptake despite variability in study designs and populations.

Original authors: Rachel McNamara, Elizabeth Randell, Rebecca Playle, Kerenza Hood, Susana Mouga, Miguel Castelo-Branco, Manfred Hallschmid, Tom Fruchtman-Steinbok, Kathrin Cohen Kadosh, Talma Hendler, David EJ Linden

Published 2026-10-09
📖 5 min read🧠 Deep dive

Original authors: Rachel McNamara, Elizabeth Randell, Rebecca Playle, Kerenza Hood, Susana Mouga, Miguel Castelo-Branco, Manfred Hallschmid, Tom Fruchtman-Steinbok, Kathrin Cohen Kadosh, Talma Hendler, David EJ Linden

Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). ✨ This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer

Imagine a way to teach the brain to heal itself, not by swallowing a pill or undergoing surgery, but by learning to control its own electrical signals in real time. This is the promise of neurofeedback, a technique where people watch a screen that shows their brain activity and learn, through practice, to nudge that activity in a helpful direction. It is like learning to ride a bicycle; at first, the balance feels impossible, but with feedback from the road and the bike, the body eventually finds the rhythm on its own. For decades, scientists have wondered if this method could help treat serious conditions like anxiety, addiction, and autism, but the research has been scattered, with small studies that were hard to compare. The big question remained: could this approach actually work in a real-world clinical setting, across different types of patients and different countries, without falling apart?

A large team of researchers from across Europe and Israel set out to answer this by running seven separate studies under one umbrella project called BRAINTRAIN. They did not just test one idea; they tested the entire system of running these trials. They looked at people struggling with alcohol dependence, post-traumatic stress disorder, autism, obesity, and anxiety in teenagers. The goal was not to prove that neurofeedback cures these conditions immediately, but to see if it was even possible to run these complex experiments successfully. They wanted to know if they could find enough volunteers, keep them coming back for multiple sessions, and deliver the treatment safely and consistently. If the machinery of the research itself was too fragile, then no amount of medical potential would matter.

The researchers organized their work with a shared blueprint. Instead of each team inventing their own rules, they used a standard plan for how to recruit people, how to handle safety, and how to measure progress. They built a single database to hold all the information and formed a joint committee to oversee the work. Some studies used a randomized design, where participants were split into groups to receive either the real brain training or a control treatment, while others simply tracked people before and after the training. The treatments varied, too. Some participants used electrodes on their heads to monitor brain waves, while others lay inside a magnetic resonance imaging machine, which takes detailed pictures of the brain, to learn how to control specific deep brain regions. The conditions they treated were as different as a teenager with high anxiety and an adult recovering from alcohol dependence, yet the team applied the same rigorous standards to all of them.

The results showed that the entire approach was feasible. Across all seven studies, the teams managed to recruit the people they needed and keep the vast majority of them engaged until the end. For example, in the study involving alcohol dependence, they successfully enrolled 52 people and kept 69 percent of them through the final follow-up. In the study on autism, they retained 100 percent of their participants through the intervention and the follow-up period. Even in the more difficult study on preventing post-traumatic stress disorder in people who had just experienced a traumatic event, the team managed to keep 91 percent of their participants. The researchers found that while some groups were harder to keep than others, no study failed to meet the basic requirements for moving forward. The volunteers generally found the experience acceptable, and the treatment was delivered as planned without major safety issues.

There were, of course, small bumps along the road. In the study with teenagers who had anxiety, many families expressed interest but could not make the appointments due to busy schedules, leading to a higher drop-out rate before the treatment even began. In the study on obesity, the group receiving the real brain training had slightly lower attendance than the group receiving a fake version, though both groups finished the study. These variations did not stop the project; instead, they offered a clear map of what needs to be fixed for future, larger trials. The researchers noted that simple things, like sending text message reminders or being more flexible with scheduling, could help improve these numbers. They also learned that the fear of being inside a large scanner was not a major barrier; once people understood what was happening, they were willing to return for repeated sessions.

The most important finding is that neurofeedback is a practical tool that can be delivered across a wide range of mental and behavioral health issues. The study proved that it is possible to run these complex, high-tech experiments in a coordinated way across different hospitals and countries. The researchers did not claim to have solved these disorders, nor did they say the treatment works for everyone. They simply showed that the path is open. The machinery works, the people can be recruited, and the treatment can be delivered safely. This clears the way for the next step: larger, more definitive studies that can finally tell us if this method of teaching the brain to regulate itself can truly change lives for those suffering from these difficult conditions.

Drowning in papers in your field?

Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.

Try Digest →